文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

一种探索美国大型重症监护数据库中呼吸机相关事件监测定义变异的方法

A Method to Explore Variations of Ventilator-Associated Event Surveillance Definitions in Large Critical Care Databases in the United States.
PubMed 文献 · Crit Care Explor · 2022-11-15
一句话结论开发了一套统计框架与交互式可视化工具,用于量化呼吸机相关事件监测定义中第一层(VAC)变更对预后表现的影响。

该研究为回顾性、多中心、横断面分析,覆盖209家医院340个重症监护单元,来自eICU-CRD和MIMIC-III数据库共261,910例患者,其中14,517例接受机械通气≥4天。作者设计了统计分析框架和自定义交互式数据可视化工具,比较有无VAC患者的医院死亡率、医院住院时长和ICU住院时长,并可按数据集、ICU类型、最低FiO2、最低PEEP、早发/晚发VAC及首日最差呼吸序贯器官衰竭评估评分分层。结果显示该方法和工具可展示VAC监测定义变化对预后表现的影响,为在不同人群、时间和重症监护设置中量化定义变异提供了手段。

要点

  • 研究纳入261,910例患者(209家医院340个ICU),其中14,517例机械通气≥4天,用于分析VAC监测定义变异。
  • 该方法比较有无VAC患者的医院死亡率、医院住院时长和ICU住院时长三项结局。
  • 可按患者人群(数据集和ICU类型)及临床特征(最低FiO2、最低PEEP、早发/晚发VAC、首日最差呼吸SOFA评分)共六项标准分层。
  • 患者人群结局以热图展示死亡率比值比,通气设置变异和临床特征结局以Kaplan-Meier生存曲线展示。
  • 作者开发了交互式工具,用于可视化和量化VAC监测定义变异在不同人群、时间和重症监护设置中的影响。

适用人群与场景

  • 来自eICU-CRD和MIMIC-III数据库的261,910例患者,涵盖209家医院340个重症监护单元。
  • 其中14,517例接受机械通气4天或以上,为VAC分析人群。

研究设计与关键结果

  • 研究类型为回顾性、多中心、横断面分析,覆盖209家医院340个重症监护单元,共261,910例患者,其中14,517例机械通气≥4天。
  • 开发了统计分析框架和自定义交互式数据可视化工具,用于展示VAC监测定义变化如何改变其预后表现,比较有无VAC患者。
  • 该方法和工具可比较三项临床结局:医院死亡率、医院住院时长和ICU住院时长。
  • 可按六项标准分层:患者人群(数据集和ICU类型)及临床特征(最低FiO2、最低PEEP、早发/晚发VAC、首日最差呼吸SOFA评分)。
  • 患者人群结局以热图展示死亡率比值比;通气设置变异和临床特征结局以Kaplan-Meier生存曲线展示。

证据类型、等级与局限

  • 证据类型:回顾性、多中心、横断面分析。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: The Centers for Disease Control has well-established surveillance programs to monitor preventable conditions in patients supported by mechanical ventilation (MV). The aim of the study was to develop a data-driven methodology to examine variations in the first tier of the ventilator-associated event surveillance definition, described as a ventilator-associated condition (VAC). Further, an interactive tool was designed to illustrate the effect of changes to the VAC surveillance definition, by applying different ventilator settings, time-intervals, demographics, and selected clinical criteria.

DESIGN: Retrospective, multicenter, cross-sectional analysis.

SETTING: Three hundred forty critical care units across 209 hospitals, comprising 261,910 patients in both the electronic Intensive Care Unit Clinical Research Database and Medical Information Mart for Intensive Care III databases.

PATIENTS: A total of 14,517 patients undergoing MV for 4 or more days.

MEASUREMENTS AND MAIN RESULTS: We designed a statistical analysis framework, complemented by a custom interactive data visualization tool to depict how changes to the VAC surveillance definition alter its prognostic performance, comparing patients with and without VAC. This methodology and tool enable comparison of three clinical outcomes (hospital mortality, hospital length-of-stay, and ICU length-of-stay) and provide the option to stratify patients by six criteria in two categories: patient population (dataset and ICU type) and clinical features (minimum Fio2, minimum positive end-expiratory pressure, early/late VAC, and worst first-day respiratory Sequential Organ Failure Assessment score). Patient population outcomes were depicted by heatmaps with mortality odds ratios. In parallel, outcomes from ventilation setting variations and clinical features were depicted with Kaplan-Meier survival curves.

CONCLUSIONS: We developed a method to examine VAC using information extracted from large electronic health record databases. Building upon this framework, we developed an interactive tool to visualize and quantify the implications of variations in the VAC surveillance definition in different populations, across time and critical care settings. Data for patients with and without VAC was used to illustrate the effect of the application of this method and visualization tool.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Wong AI, Kim H, Charpignon ML, et al. A Method to Explore Variations of Ventilator-Associated Event Surveillance Definitions in Large Critical Care Databases in the United States. Crit Care Explor. 2022. PMID: 36406886. doi:10.1097/CCE.0000000000000790

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。